IIT researchers develop promising TB diagnostics solution
Ravi Elangovan’s decision to leave a cushy research job in Florence and join IIT-Delhi’s faculty in 2010 was driven mostly by personal reasons.
DetailsRavi Elangovan’s decision to leave a cushy research job in Florence and join IIT-Delhi’s faculty in 2010 was driven mostly by personal reasons.
DetailsUS drug maker Johnson and Johnson will offer its new tuberculosis (TB) drug, Bedaquiline, at $900 (Rs 70,000) once its conditional access programme with the government of India ends in 2019, the company said in an interview to ET.
DetailsLONDON: Scientists are developing an eye drop that could revolutionise the treatment for age-related macular degeneration (AMD), the leading cause of blindness in the developed world.
DetailsFor men planning for fatherhood, regularly consuming a good of nuts can significantly improve men’s firtility and sperm mobility.
DetailsAminex Therapeutics, Inc., a clinical-stage drug development company focused on advancing a novel cancer immunotherapy, announced it received clearance from the FDA to initiate the first Phase 1 clinical trial of its immuno-oncology drug candidate AMXT 1501.
Details